⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28164893 | 0.97 | — | — | |
| SCHEMBL31054136 | 0.82 | CA1 (0.33) | — | |
| SCHEMBL564320 | 0.80 | — | — | |
| Ammonia Solution, Strong SCHEMBL27628534 | 0.78 | — | — | |
| SCHEMBL8357696 | 0.78 | CA2 (0.42) | — | |
| SCHEMBL28302064 | 0.78 | CA2 (0.33) | — | |
| SCHEMBL5078137 | 0.76 | — | — | |
| SCHEMBL27884945 | 0.75 | — | — | |
| SCHEMBL7214 | 0.75 | — | — | |
| SCHEMBL5075504 | 0.74 | CA1 (0.58) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025122770-A1 | STENTS AND TOPICAL COMPOSITIONS COMPRISING THIOSULFATE | SHIN MICHAEL (US) | 2025-06-12 | — | — | WO | disclosed |
| CN-119894878-A | Aromatic amide derivative and preparation method and application thereof | 浙江海正药业股份有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-119100946-A | Synthesis method of key intermediate of rilpivirine | 石家庄龙泽制药股份有限公司 | 2024-12-10 | — | — | CN | disclosed |
| CN-118285384-A | In-situ fumigation method for controlling mold disease of tomb wall painting | 中国科学院上海有机化学研究所 | 2024-07-05 | — | — | CN | disclosed |
| WO-2024078569-A1 | AROMATIC AMIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 浙江海正药业股份有限公司 | 2024-04-18 | — | — | WO | disclosed |
| CN-112321805-B | Indacen-4-one derivatives, process for their preparation and polymers containing them | 艾尼股份公司 | 2023-09-19 | — | — | CN | disclosed |
| CN-114478528-A | Aroyl-substituted tricyclic compound, preparation method and application thereof | 劲方医药科技(上海)有限公司 | 2022-05-13 | — | — | CN | disclosed |
| CN-114364378-A | Cancer immunotherapy | 阿克塞利阿肿瘤学私人有限公司 | 2022-04-15 | — | — | CN | disclosed |
| CN-102633702-B | Beta-amino ethyl thiosulfuric acid and synthesis method thereof | GUANGZHOU JENYI BIO TECH CO LTD | 2014-01-15 | — | — | CN | disclosed |
| CN-102633702-B | Beta-amino ethyl thiosulfuric acid and synthesis method thereof | GUANGZHOU JENYI BIO TECH CO LTD | 2014-01-15 | — | — | CN | disclosed |
| CN-102633702-A | Beta-amino ethyl thiosulfuric acid and synthesis method thereof | GUANGZHOU JENYI BIO TECH CO LTD | 2012-08-15 | — | — | CN | disclosed |
| CN-102633702-A | Beta-amino ethyl thiosulfuric acid and synthesis method thereof | GUANGZHOU JENYI BIO TECH CO LTD | 2012-08-15 | — | — | CN | disclosed |
| CN-1287218-C | Silver halide photographic optical sensitive material | FUJI PHOTO FILM CO LTD (JP) | 2006-11-29 | — | — | CN | disclosed |
| CN-1161333-C | Oxindole derivatives as growth hormone releasers | ס����ҩ��ʽ���� | 2004-08-11 | — | — | CN | disclosed |
| CN-1346073-A | Silver halide photographic optical sensitive material | FUJI PHOTO FILM CO LTD (JP) | 2002-04-24 | — | — | CN | disclosed |
| CN-1313853-A | Oxindole derivatives as growth hormone releasers | SUMITOMO PHARMA (JP) | 2001-09-19 | — | — | CN | disclosed |
| EP-0822958-B1 | HALOGENATED ELASTOMER COMPOSITIONS | MONSANTO CO (US) | 2001-06-20 | — | — | EP | disclosed |
| US-6207764-B1 | ELASTOMERIC INTERPOLYMERS CONTAINING HALOGENATED COPOLYMER OF C4-C7 ISOOLEFIN AND PARA-ALKYLSTYRENE, A CROSSLINKING AGENT AND A THIOSULFATE ACCELERATOR | MONSANTO COMPANY | 2001-03-27 | — | — | US | disclosed |
| EP-0822958-A1 | HALOGENATED ELASTOMER COMPOSITIONS | MONSANTO COMPANY (US) | 1998-02-11 | — | — | EP | disclosed |
| WO-1996034043-A1 | HALOGENATED ELASTOMER COMPOSITIONS | MONSANTO COMPANY (US) | 1996-10-31 | — | — | WO | disclosed |